Between 2013 and 2023, the Latvian market size for Hormones in Dosage Except Contraceptives and Antibiotics showed fluctuations, with the market reaching a value of 48.394 million USD in 2023. The year-on-year growth was a modest 0.41%, recovering slightly from an 8.71% decline in 2022, indicative of its volatile nature. The last five-year compound annual growth rate (CAGR) was relatively flat at 0.43%, signaling limited growth over this period.
Future trends to watch for include:
- Regulatory changes affecting market dynamics and pricing.
- Advancements in hormone therapies potentially driving demand.
- Evolving public perception and acceptance of hormone treatments.
- The impact of global economic conditions on healthcare spending.
